TENT-A2 Results Paper
Neuromod has published the results of the company's TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2) clinical trial in Nature - Scientific Reports in a paper titled: ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.
Access the Paper
See Supplementary Materials
The study is the Neuromod's second large-scale clinical trial conducted in the tinnitus field with 191 enrolled participants, providing further evidence regarding the safety and patient tolerability of bimodal neuromodulation for the treatment of tinnitus while demonstrating greater efficacy of reducing tinnitus symptoms than the first large-scale trial, TENT-A1. 95% of treatment compliant participants reported an improvement in tinnitus symptom severity when evaluated after 12 weeks of treatment, with many experiencing sustained benefit 12 months post-treatment.